相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis An Integral Model
Moises Selman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation
Lei Wang et al.
CARDIOVASCULAR RESEARCH (2014)
Transcriptional Repression of the Transforming Growth Factor β (TGF-β) Pseudoreceptor BMP and Activin Membrane-bound Inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 Enhances TGF-β Signaling in Hepatic Stellate Cells
Cheng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cellular and molecular mechanisms in kidney fibrosis
Jeremy S. Duffield
JOURNAL OF CLINICAL INVESTIGATION (2014)
Epstein-Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast-Myofibroblast Conversion in Scleroderma
Antonella Farina et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
FibronectinEDA Promotes Chronic Cutaneous Fibrosis Through Toll-like Receptor Signaling
Swati Bhattacharyya et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis
Giuseppina Stifano et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis How Similar and Distinct?
Erica L. Herzog et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma
Swati Bhattacharyya et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
David N. O'Dwyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
Lara Bossini-Castillo et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
Marzena Ciechomska et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Genetics of scleroderma: implications for personalized medicine?
Shervin Assassi et al.
BMC MEDICINE (2013)
Role of toll-like receptors in systemic sclerosis
Marzena Ciechomska et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2013)
A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling
Feng Fang et al.
JOURNAL OF IMMUNOLOGY (2013)
Danger Signals in the Initiation of the Inflammatory Response after Myocardial Infarction
J. J. de Haan et al.
MEDIATORS OF INFLAMMATION (2013)
Recurrent Exposure to Subclinical Lipopolysaccharide Increases Mortality and Induces Cardiac Fibrosis in Mice
Wilbur Y. W. Lew et al.
PLOS ONE (2013)
Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
Jing Li et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
TLR4 Activity Is Required in the Resolution of Pulmonary Inflammation and Fibrosis after Acute and Chronic Lung Injury
Hong-Zhen Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators
J. C. A. Broen et al.
ARTHRITIS AND RHEUMATISM (2012)
Brief Report: Candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity
Eugenie Koumakis et al.
ARTHRITIS AND RHEUMATISM (2012)
Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice
Markus Velten et al.
CARDIOVASCULAR RESEARCH (2012)
The genetics of scleroderma: looking into the postgenomic era
Maureen D. Mayes
CURRENT OPINION IN RHEUMATOLOGY (2012)
Gadolinium Compounds Signaling through TLR 4 and TLR 7 in Normal Human Macrophages: Establishment of a Proinflammatory Phenotype and Implications for the Pathogenesis of Nephrogenic Systemic Fibrosis
Peter J. Wermuth et al.
JOURNAL OF IMMUNOLOGY (2012)
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance-Forming Modification
Marina Oldenburg et al.
SCIENCE (2012)
Dissecting negative regulation of Toll-like receptor signaling
Takeshi Kondo et al.
TRENDS IN IMMUNOLOGY (2012)
Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis
Cory M. Hogaboam et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Fibrosis in systemic sclerosis: common and unique pathobiology
Swati Bhattacharyya et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Negative regulation of signaling by a soluble form of toll-like receptor 9
Annapoorani Chockalingam et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
A trio of microRNAs that control Toll-like receptor signalling
Susan R. Quinn et al.
INTERNATIONAL IMMUNOLOGY (2011)
Toll-Like Receptors Expressed by Dermal Fibroblasts Contribute to Hypertrophic Scarring
Jianfei Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Upregulation of Toll-Like Receptors (TLRs) 6, 7, and 8 in Keloid Scars
Rania A. Bagabir et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction
Gemma Vilahur et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis
Matthew T. Campbell et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Innate immune signaling in cardiac ischemia
Fatih Arslan et al.
NATURE REVIEWS CARDIOLOGY (2011)
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts
Sandeep K. Agarwal et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB As Novel Risk Loci for Systemic Sclerosis
Yannick Allanore et al.
PLOS GENETICS (2011)
The First Type III Domain of Fibronectin is Associated with the Expression of Cytokines within the Lung Tumor Microenvironment
Mingzhe Zheng et al.
JOURNAL OF CANCER (2011)
TLR9-induced interferon beta is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis
Tracy R. Luckhardt et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Latent Herpesvirus Infection Augments Experimental Pulmonary Fibrosis
Kevin M. Vannella et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis
L. van Bon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-and TRIF-dependent signaling
Shijun Wang et al.
DISEASE MODELS & MECHANISMS (2010)
COMBINED Tlr2 AND Tlr4 DEFICIENCY INCREASES RADIATION-INDUCED PULMONARY FIBROSIS IN MICE
Alexandra Paun et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis
Giuseppina A. Farina et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal Injury
Wilco P. Pulskens et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Glenda Trujillo et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers
C. L. Bos et al.
GENES AND IMMUNITY (2009)
Transforming growth factor β as a therapeutic target in systemic sclerosis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study
ZhengYu He et al.
RESPIRATORY RESEARCH (2009)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
Antifibroblast Antibodies in Systemic Sclerosis Induce Fibroblasts to Produce Profibrotic Chemokines, With Partial Exploitation of Toll-like Receptor 4
Serena Fineschi et al.
ARTHRITIS AND RHEUMATISM (2008)
Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis
Won-Il Jeong et al.
GASTROENTEROLOGY (2008)
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice
Alexander Riad et al.
JOURNAL OF IMMUNOLOGY (2008)
New insights into form and function of fibronectin splice variants
E. S. White et al.
JOURNAL OF PATHOLOGY (2008)
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLOS ONE (2008)
Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis
Yoshifumi Tada et al.
ARTHRITIS RESEARCH & THERAPY (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105
Senad Divanovic et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients
FK Tan et al.
RHEUMATOLOGY (2006)
Toll-like receptor signaling in the liver
Robert F. Schwabe et al.
GASTROENTEROLOGY (2006)
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
DH Jiang et al.
NATURE MEDICINE (2005)
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105
S Divanovic et al.
NATURE IMMUNOLOGY (2005)
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
JS Duffield et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
IE Wertz et al.
NATURE (2004)
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
DL Boone et al.
NATURE IMMUNOLOGY (2004)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
分享论文
